What Happens When You Stop Taking a GLP-1?

Oct 20

Why maintaining weight loss can be harder than achieving it—and what that reveals about how the body regulates itself.

In my last article, GLP-1s Beyond Weight Loss: What They Reveal About the Connected Body, I explored something fascinating about GLP-1 medications: how changing a relatively small number of biological signals can produce effects throughout the body.

Appetite changes. Weight changes. Glucose regulation improves. Blood pressure may fall. And in some cases, the benefits extend to the heart, kidneys, liver, and sleep.

But there's another side to that story.

What happens when we stop changing those signals?

As GLP-1 medications have become increasingly popular, this question has attracted growing attention. And the research is beginning to give us an answer.

Research on weight regain after stopping GLP-1 medications suggests that many people regain a substantial amount of the weight they lost during treatment.

But I think the more interesting question is why.

Because the answer takes us beyond GLP-1 medications and into something fundamental about how the body works.

Why can achieving a biological change be so much easier than maintaining it?

What Happens When You Stop Taking GLP-1 Medications?

One of the clearest demonstrations comes from research on semaglutide, the medication in Wegovy and Ozempic.

In an extension of the STEP 1 clinical trial, participants had lost an average of about 17% of their body weight during treatment. A year after stopping both the medication and structured lifestyle support, they had regained approximately two-thirds of that weight loss.

Improvements in several cardiometabolic risk factors also moved back toward their original levels.

A similar pattern emerged in the SURMOUNT-4 trial of tirzepatide, the medication in Zepbound and Mounjaro.

After losing an average of about 21% of their starting weight, participants were randomly assigned either to continue taking tirzepatide or switch to a placebo.

Over the following year, those who continued treatment lost additional weight. Those who stopped regained a substantial amount—even though they continued receiving diet and physical activity counseling.

These findings don't mean everyone will regain the same amount of weight, or that maintaining weight loss without medication is impossible. Some participants maintained meaningful weight reductions after stopping.

But the overall pattern is striking.

The changes achieved during treatment don't necessarily sustain themselves once treatment ends.

For someone considering stopping a GLP-1 medication, appetite may increase, weight may gradually return, and some improvements in metabolic health may diminish. Individual experiences vary, and people using these medications for diabetes may need adjustments to their glucose management.

Anyone considering discontinuing treatment should discuss it with their healthcare professional.

But beyond those practical considerations, the findings raise a fascinating question.

Why don't the benefits of medication necessarily persist after we stop taking it?

The Body Doesn't See Weight Loss as a Finished Project

We often talk about weight loss as though it were a project with a beginning, middle, and end.

You make a change. You lose weight. And then, presumably, you get to enjoy the results.

But the body doesn't necessarily recognize that you've reached your goal.

Body weight is regulated through a network of signals involving the brain, digestive system, hormones, fat tissue, and energy expenditure.

And as research on the physiology of weight regain explains, those systems respond to weight loss.

Hunger may increase. Satiety signals can change. Energy expenditure may decline—not only because a smaller body requires less energy, but also because of physiological adaptations that can make maintaining weight loss more difficult.

GLP-1 medications influence some of these processes, helping regulate appetite and food intake.

When treatment stops, that pharmacological support diminishes.

The weight may have changed. But the processes involved in regulating it haven't necessarily been permanently reset.

The Problem With Before and After

We love a good before-and-after story.

Someone makes a change, puts in the work, and gets the result they wanted.

The story ends there.

But real life doesn't.

The holidays arrive, with all their rich food and sweets. A demanding work project takes over, and suddenly there's less time for exercise or preparing meals. Sleep gets disrupted. Family responsibilities increase.

Routines that once felt manageable become harder to maintain.

And gradually, old habits can return.

This is often described as a problem of discipline.

But I've never found that explanation particularly satisfying.

Most people aren't living in stable, predictable environments where they can make the same choices under the same circumstances every day.

They're adapting to changing demands on their time, energy, attention, and resources.

And their bodies are adapting, too.

Maintaining weight isn't simply a matter of repeating the behaviors that helped us lose it. It's a process of continually adapting those behaviors to changing circumstances—while the body itself is changing.

That's true whether someone loses weight through dietary changes, exercise, medication, or some combination.

But GLP-1 medications introduce another dimension.

During treatment, the medication is helping regulate appetite and food intake.

When treatment ends, that support is no longer there.

So we're not necessarily asking someone to maintain the same behaviors under the same conditions.

We're asking them to maintain the same outcome under different conditions.

And that may be a much harder task.

Did the Medication Change the System—or Just Support It?

This is the distinction I keep coming back to.

There's a difference between changing how a biological system functions while we're intervening in it and permanently changing the processes that regulate that system.

Consider blood pressure.

Someone takes medication, and their blood pressure improves.

If they stop taking the medication, their blood pressure may rise again.

We don't generally interpret that as evidence that the medication failed.

We understand that the medication was helping manage an ongoing physiological condition.

The same is true for many treatments for diabetes and other chronic diseases.

GLP-1 medications raise a similar question about obesity and weight regulation.

If a medication helps regulate appetite, food intake, and metabolic processes, why would we necessarily expect those effects to continue after the medication is removed?

The expectation seems particularly interesting because we don't always apply it consistently across medical conditions.

We generally accept that some conditions require ongoing treatment.

Yet weight loss is often presented as something that should eventually become self-sustaining, provided someone has developed the right habits.

Healthy habits certainly matter.

But they operate within a biological system that continues to respond to weight loss, food intake, activity, and the surrounding environment.

An intervention can be remarkably effective without actually fixing the problem.

That doesn't mean everyone who starts a GLP-1 medication will need to take it forever.

It means we should distinguish between successfully treating a condition and permanently eliminating the processes that made treatment helpful.

What Does It Take to Make Change Last?

If maintaining weight loss is an ongoing process, what actually helps?

Nutrition, physical activity, resistance exercise, sleep, and consistent routines can all support health and weight management.

But even well-established habits don't necessarily eliminate the physiological responses to weight loss.

Someone can continue eating nutritious food, exercising regularly, and paying attention to their health while still experiencing increased hunger or some weight regain.
That doesn't mean those habits aren't helping.
It means they're only part of a larger regulatory system.

For some people, continued medication may be an important part of long-term weight management. For others, different treatment strategies or forms of support may be appropriate.

And there are practical considerations. Long-term medication can be expensive. Insurance coverage changes. Side effects may become difficult to tolerate. Some people simply don't want to remain on treatment indefinitely.

So perhaps the question isn't only how to maintain weight loss.

It's how to create the conditions that make maintaining health possible over time.

The Bigger Picture: Health Doesn't Have a Finish Line

The more I think about GLP-1 medications, the more they seem to challenge some of our assumptions about what successful treatment looks like.

We've become accustomed to thinking about weight loss as an achievement.

Something we work toward, accomplish, and then maintain.

But biological systems don't work quite that way.

They're constantly adjusting to changing conditions.

A healthy system isn't necessarily one that reaches an ideal state and remains there effortlessly.
It's one that can continue to regulate and adapt as circumstances change.

Of course, maintaining a particular weight isn't the same thing as maintaining health. Strength, metabolic function, physical capacity, and quality of life matter, too.

And a change on the scale doesn't tell us everything about any of those things.

But the experience of stopping GLP-1 medications reveals something important about the ongoing nature of biological regulation.

The first GLP-1 story was about how much can change when we intervene in one part of the body.

This one is about what happens when that intervention ends.

Maybe the problem with the weight-loss story isn't that people fail to reach the finish line.

It's that we've been telling them there is one.